Clinical Trial Update: VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial from Shanghai BDgene is evaluating a VEGFA-targeting gene therapy for neovascular age-related macular degeneration, diabetic macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• VEGFA-targeting Gene Therapy

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING